Ontology highlight
ABSTRACT:
SUBMITTER: Ascierto PA
PROVIDER: S-EPMC6042369 | biostudies-literature | 2018 Jul
REPOSITORIES: biostudies-literature
Ascierto Paolo A PA Brugarolas James J Buonaguro Luigi L Butterfield Lisa H LH Carbone David D Daniele Bruno B Ferris Robert R Fox Bernard A BA Galon Jérôme J Gridelli Cesare C Kaufman Howard L HL Klebanoff Christopher A CA Melero Ignacio I Nathan Paul P Paulos Chrystal M CM Ruella Marco M Sullivan Ryan R Zarour Hassane H Puzanov Igor I
Journal for immunotherapy of cancer 20180711 1
Immunotherapy represents the third important wave in the history of the systemic treatment of cancer after chemotherapy and targeted therapy and is now established as a potent and effective treatment option across several cancer types. The clinical success of anti-cytotoxic T-lymphocyte-associated antigen (CTLA)-4, first, and anti-programmed death (PD)-1/PD-ligand (L)1 agents in melanoma and other cancers a few years later, has encouraged increasing focus on the development of other immunotherap ...[more]